Literature DB >> 18762957

Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients.

Mehdi Nassiri1, Heather Woolery-Lloyd, Sharon Ramos, Sharon E Jacob, Dijana Gugic, Anita Viciana, Paolo Romanelli, George Elgart, Brian Berman, Vladimir Vincek.   

Abstract

Excessive scar formation in keloids points to altered tissue modeling and repair mechanisms. Dysregulation of cytokine and apoptotic cascades and their downstream signaling pathways might have a role in keloid development. Total RNA was isolated from biopsied keloidal tissue and adjacent normal skin of black patients, white patient's scars, and normal skin of black and white patients, with normal wound healing. Apoptosis, cytokine and NFkB pathway microarrays were used to study and compare gene expression levels. Real-time PCR was used to verify microarray results in original samples and a separate, validation-set of samples. Significant differences were observed in the expression levels of members of caspase, cytokines and MAP kinase pathways, between the normal skin of keloid-prone and normal skin of keloid-resistant patients. Specifically, expression of caspase 6, and caspase 14 genes were different between normal skin of keloid-prone individuals and normal skin of keloid-resistant patients. Our results suggest that normal skin of keloid-prone individuals constitutively expresses a distinct gene profile which might contribute to their susceptibility to develop keloids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762957     DOI: 10.1007/s00403-008-0880-z

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  6 in total

1.  Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids.

Authors:  Shigeki Inui; Fumie Shono; Takeshi Nakajima; Ko Hosokawa; Satoshi Itami
Journal:  Am J Pathol       Date:  2011-08-26       Impact factor: 4.307

2.  Aberrant connective tissue differentiation towards cartilage and bone underlies human keloids in African Americans.

Authors:  Judilyn Fuentes-Duculan; Kathleen M Bonifacio; Mayte Suárez-Fariñas; Norma Kunjravia; Sandra Garcet; Tristan Cruz; Claire Q F Wang; Hui Xu; Patricia Gilleadeau; Mary Sullivan-Whalen; Michael H Tirgan; James G Krueger
Journal:  Exp Dermatol       Date:  2017-02-28       Impact factor: 3.960

3.  Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars.

Authors:  Victor W Wong; Fanglei You; Michael Januszyk; Geoffrey C Gurtner; Anna A Kuang
Journal:  Ann Plast Surg       Date:  2014       Impact factor: 1.539

4.  Keloid Management: A Retrospective Case Review on a New Approach Using Surgical Excision, Platelet-Rich Plasma, and In-office Superficial Photon X-ray Radiation Therapy.

Authors:  Michael E Jones; Cherrell Hardy; Julie Ridgway
Journal:  Adv Skin Wound Care       Date:  2016-07       Impact factor: 2.347

5.  RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17/Th22, and JAK3-Skewing.

Authors:  Jianni Wu; Ester Del Duca; Michael Espino; Alyssa Gontzes; Inna Cueto; Ning Zhang; Yeriel D Estrada; Ana B Pavel; James G Krueger; Emma Guttman-Yassky
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

6.  Inhibition of CUB and sushi multiple domains 1 (CSMD1) expression by miRNA-190a-3p enhances hypertrophic scar-derived fibroblast migration in vitro.

Authors:  Shuchen Gu; Xin Huang; Xiangwen Xu; Yunhan Liu; Yimin Khoong; Zewei Zhang; Haizhou Li; Yashan Gao; Tao Zan
Journal:  BMC Genomics       Date:  2021-08-12       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.